-
141
Enhancing oncology patient care: nurses’ knowledge, attitudes, and perceived benefits of early palliative integration - a cross-sectional study
Published 2025-01-01“…Data were collected using paper based self-administered questionnaires from nurses working in hematology, general oncology, and bone marrow transplantation departments. Results Among of 128 nurses, the study revealed a moderate level of knowledge (3.64 ± 0.96), Positive attitude (3.59 ± 1.02) and moderately recognized the perceived benefits of early palliative care (3.57 ± 1.02). …”
Get full text
Article -
142
-
143
HLA-G Expression on Blasts and Tolerogenic Cells in Patients Affected by Acute Myeloid Leukemia
Published 2014-01-01Get full text
Article -
144
-
145
Effect of Hematopoietic Stem Cell Transplantation Regimen on Tacrolimus Pharmacokinetics
Published 2025-01-01“…Results: We enrolled 91 patients undergoing HSCT (CBT: n = 56; bone marrow transplantation: n = 22; and peripheral blood stem cell transplantation: n = 13); 58 and 33 patients received myeloablative conditioning and reduced-intensity conditioning, respectively. …”
Get full text
Article -
146
De Novo Acute Myeloid Leukemia with Combined CBFB-MYH11 and BCR-ABL1 Gene Rearrangements: A Case Report and Review of Literature
Published 2020-01-01“…Eventually, bone marrow transplantation was contraindicated, and the patient was transferred to palliative care. …”
Get full text
Article -
147
-
148
Annexin A8 deficiency delays atherosclerosis progression
Published 2025-01-01“…ApoE−/− mice lacking systemic AnxA8 (ApoE−/−AnxA8−/−) were generated to assess the effect of AnxA8 deficiency on atherosclerosis. Bone marrow transplantation (BMT) was also performed to generate ApoE−/− lacking AnxA8 specifically in bone marrow‐derived cells. …”
Get full text
Article -
149
-
150
Clonal hematopoiesis in patients with autoimmune thrombocytopenia: an international multicenter study
Published 2025-02-01Get full text
Article -
151
-
152
-
153
Second-line treatment patterns and outcomes in advanced HCC after progression on atezolizumab/bevacizumab
Published 2025-02-01Get full text
Article